CompletedPhase 2NCT00570661
Open Label, Multicentre Trial to Assess Safety and Efficacy of ITF2357 in Active Systemic Juvenile Idiopathic Arthritis
Studying Juvenile idiopathic arthritis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Italfarmaco
- Principal Investigator
- Nemanja Damjanov, MD, PhDInstitute of Rheumatology Belgrade
- Intervention
- ITF2357(drug)
- Enrollment
- 17 enrolled
- Eligibility
- 2-25 years · All sexes
- Timeline
- 2006 – 2013
Study locations (5)
- Clinica Institute Fundeni.Pediatric Clinic 258 Sos. Fundeni,, Bucharest, Romania
- Clinical Emergency Children Hospital "M.S. Curie" Paediatric Clinic no. I 20 Ctin. Brancoveanu Bvd., 041451 Bucharest 4th district, Bucharest, Romania
- University Clinical Centre NisClinic of Paediatrics Department for Rheumatology Bul Dr Zoran Djindjica, Niš, Nis, Serbia
- Mother and Child Health Institute "Dr. Vukan Cupic" Clinic of Paediatrics Radoja Dakica, Belgrade, Novi Belgrade, Serbia
- Institute of Rheumatology Belgrade Resavska, Belgrade, Serbia
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00570661 on ClinicalTrials.govOther trials for Juvenile idiopathic arthritis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07553182OLE Study With Filgotinib in JIAAlfasigma S.p.A.
- ENROLLING BY INVITATIONPHASE3NCT07386587Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic ArthritisUniversity of Child Health Sciences and Children's Hospital, Lahore
- RECRUITINGPHASE3NCT06654882Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisDuke University
- RECRUITINGNCT07243782Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cosentyx®(Secukinumab) in KoreaNovartis Pharmaceuticals
- RECRUITINGNANCT07217782Pain in Juvenile ArthritisWashington University School of Medicine
- RECRUITINGNCT07185750Investigation of Catastrophizing of Pain Reported by Parents in JIA PatientsHacettepe University
- RECRUITINGNCT06718569Pain in Inflammatory Joint DiseasesDiakonhjemmet Hospital
- RECRUITINGNCT06806774Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopathic ArthritisHacettepe University